A multicenter, prospective, cohort study to investigate the incidence and clinical management of CMV infection in adult patients with hematological malignancies following allogeneic hematopoietic stem cell transplantation in China

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/45841
• EU PAS number:
  EUPAS45840
• Study ID:
  45841
• Official title and acronym:
  A multicenter, prospective, cohort study to investigate the incidence and clinical management of CMV infection in adult patients with hematological malignancies following allogeneic hematopoietic stem cell transplantation in China
• DARWIN EU® study:
  No
• Study countries:
  China
• Study status:
  Ongoing

Research institutions and networks

Institutions

The First Affiliated Hospital of Soochow University

Peking Union Medical College Hospital

Peking University People`s Hospital Beijing, southern medical university nanfang hospital Guangzhou, Chinese Academy Of Medical Sciences（Peking Union Medical College） Tianjin, ANHUI PROVINCIAL HOSPITAL Anhui, Henan Provincial Cancer Hospital Henan, The First Affiliated Hospital of Zhenzhou University Zhenzhou, Beijing Friendship Hospital, Capital Medical University Beijing, Guangzhou first municipal people's hospital Guangzhou, The Shandong province owned hospital Shandong, The First Affiliated Hospital of Xinjiang Medical University xinjiang

Study timelines

Date when funding contract was signed

Actual: 17/11/2020

Study start date

Actual: 13/08/2021

Date of final study report

Planned: 31/12/2024

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

MSD (China) Holding Co., Ltd.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable